Health and Healthcare

AbbVie : ABBV

All AbbVie Articles

584 Articles

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jun 26, 2019 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

The top analyst upgrades, downgrades and initiations on Wednesday included AbbVie, Archer Daniels Midland, ConocoPhillips, FedEx, Fox, Kinder Morgan, Lennar,…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 25, 2019 at 11:45 AM EDT

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Allergan shares jumped on Tuesday after the company announced that it would be acquired by AbbVie in a cash and…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Apr 29, 2019 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

The top analyst upgrades, downgrades and initiations seen on Monday included AbbVie, Adobe, American Express, Intel, 3M, Microsoft, SAP, Shopify,…

Chris Lange | Apr 26, 2019 at 8:45 AM EDT

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Apr 10, 2019 at 9:40 AM EDT

Unbelievable Swings in Big Pharma Short Interest

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Mar 19, 2019 at 10:25 AM EDT

Bad News for AbbVie and Multiple Myeloma Patients

AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA.

Chris Lange | Mar 12, 2019 at 8:35 AM EDT

Big Pharma Short Interest Backs Off, With One Huge Exception

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2019 at 8:30 AM EST

Major Pharma Sees Tremendous Rise in Short Interest

The February 15 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 16 17 18 19 20 … 39

AbbVie : ABBV

All AbbVie Articles

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Bad News for AbbVie and Multiple Myeloma Patients

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

AbbVie : ABBV

All AbbVie Articles

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: AbbVie, ADM, Conoco, FedEx, Fox, Kinder Morgan, Lennar, Micron, Slack, Virtu and More

Short Sellers Seek Direction on Big Pharma

Are Allergan Shareholders Getting Enough in the AbbVie Acquisition?

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: AbbVie, Adobe, Amex, Intel, 3M, Microsoft, SAP, Shopify, Sprint, Target and More

Big Pharma Scares Off Short Sellers

Unbelievable Swings in Big Pharma Short Interest

Major Pharma Sees a Few Wild Swings in Short Interest

Bad News for AbbVie and Multiple Myeloma Patients

Big Pharma Short Interest Backs Off, With One Huge Exception

Major Pharma Sees Tremendous Rise in Short Interest

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip